Product Details for: NUVAXOVID

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intramuscular
5UG
Pre-Filled Syringe
351(a)
NUVAXOVID
Rx
Proper Name
COVID-19 Vaccine, Adjuvanted
BLA Number
125817
Applicant
Sanofi Vaccines US Inc.
Original Approval Date
May 16, 2025
Date of First Licensure
RETURN TO SEARCH RESULTS